Learn More
Invitrogen™ MRPL40 Polyclonal Antibody

Description
Keep as concentrated solution. Predicted reactivity: Mouse (80%), Rat (80%), Rhesus Monkey (93%). Positive Control: A549, H1299, HCT-116. Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
Specifications
Specifications
| Antigen | MRPL40 |
| Applications | Western Blot |
| Classification | Polyclonal |
| Concentration | 0.75 mg/mL |
| Conjugate | Unconjugated |
| Formulation | 0.1M tris glycine with 20% glycerol and 0.01% thimerosal; pH 7 |
| Gene | MRPL40 |
| Gene Accession No. | P83565, Q9NQ50 |
| Gene Alias | 39S ribosomal protein L40, mitochondrial; L40mt; Mitochondrial large ribosomal subunit protein mL40; mitochondrial ribosomal protein L40; MRPL22; MRP-L22; Mrpl40; MRP-L40; Nlvcf; nuclear localization signal protein absent in velo-cardio-facial patients; nuclear localization signal-containing protein deleted in velocardiofacial syndrome; Nuclear localization signal-containing protein deleted in velocardiofacial syndrome homolog; up-regulated in metastasis; URIM |
| Gene Symbols | MRPL40 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.